Visani, G.; Etebari, M.; Fuligni, F.; Di Guardo, A.; Isidori, A.; Loscocco, F.; Paolini, S.; Navari, M.; Piccaluga, P.P.
Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis. Cancers 2023, 15, 1785.
https://doi.org/10.3390/cancers15061785
AMA Style
Visani G, Etebari M, Fuligni F, Di Guardo A, Isidori A, Loscocco F, Paolini S, Navari M, Piccaluga PP.
Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis. Cancers. 2023; 15(6):1785.
https://doi.org/10.3390/cancers15061785
Chicago/Turabian Style
Visani, Giuseppe, Maryam Etebari, Fabio Fuligni, Antonio Di Guardo, Alessandro Isidori, Federica Loscocco, Stefania Paolini, Mohsen Navari, and Pier Paolo Piccaluga.
2023. "Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis" Cancers 15, no. 6: 1785.
https://doi.org/10.3390/cancers15061785
APA Style
Visani, G., Etebari, M., Fuligni, F., Di Guardo, A., Isidori, A., Loscocco, F., Paolini, S., Navari, M., & Piccaluga, P. P.
(2023). Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis. Cancers, 15(6), 1785.
https://doi.org/10.3390/cancers15061785